Optimizing anemia management is the sole indication for intravenous (IV) iron administration in the patient with chronic kidney disease (CKD): Achieving and maintaining iron sufficiency is crucial to achieving and maintaining target-range hemoglobin (Hgb). Although pica (geophagia) ([1][1]) and
No takes yet. Share an insight, caveat, or question.
George R. Aronoff (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: